Drug recall · November 23, 2022
Carvedilol Tablets recall
Why: Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05
- Lots / codes
Lot #: 3150116, Exp 2/2025
- Quantity
- 2,794 bottles
- Company
- Viatris Inc, Canonsburg, PA
- Distribution
- Nationwide in the USA
- Initiated
- October 21, 2022 · Voluntary: Firm initiated
- Classified
- November 16, 2022
- Reported
- November 23, 2022
- Ended
- July 13, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carvedilol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.